RRM2B deficiency causes dATP and dGTP depletion through enhanced degradation and slower synthesis
成果类型:
Article
署名作者:
Awoyomi, Ololade Folajimi; Gorospe, Choco Michael; Das, Biswajit; Mishra, Pradeep; Sharma, Sushma; Diachenko, Olena; Nilsson, Anna Karin; Tran, Phong; Wanrooij, Paulina H.; Chabes, Andrei
署名单位:
Umea University
刊物名称:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
ISSN/ISSBN:
0027-8986
DOI:
10.1073/pnas.2503531122
发表日期:
2025-04-22
关键词:
deoxyribonucleoside triphosphate pools
immunodeficiency-virus type-1
ribonucleotide reductase
mitochondrial-dna
cell-cycle
hydroxyurea
replication
p53r2
inhibition
samhd1
摘要:
Mitochondrial DNA (mtDNA) replication requires a steady supply of deoxyribonucleotides (dNTPs), synthesized de novo by ribonucleotide reductase (RNR). In non-dividing cells, RNR consists of RRM1 and RRM2B subunits. Mutations in RRM2B cause mtDNA depletion syndrome, linked to muscle weakness, neurological decline, and early mortality. The impact of RRM2B deficiency on dNTP pools in nondividing tissues remains unclear. Using a mouse knockout model, we demonstrate that RRM2B deficiency selectively depletes dATP and dGTP, while dCTP and dTTP levels remain stable or increase. This depletion pattern resembles the effects of hydroxyurea, an inhibitor that reduces overall RNR activity. Mechanistically, we propose that the depletion of dATP and dGTP arises from their preferred degradation by the dNTPase SAMHD1 and the lower production rate of dATP by RNR. Identifying dATP and dGTP depletion as a hallmark of RRM2B deficiency provides insights for developing nucleoside bypass therapies to alleviate the effects of RRM2B mutations.
来源URL: